
    
      To assess the pharmacokinetics of buprenorphine and its metabolites (nor-buprenorphine,
      buprenorphine 3 glucuronide and nor-buprenorphine glucuronide) in the presence and absence of
      ketoconazole.

      Safety evaluation of BTDS and ketoconazole in healthy subjects.
    
  